Back to Search
ANDREA KING, SLP
SLP
Speech-Language Pathologist
NPI: 1912212713Individual
Specialties, Licenses & Credentials
Speech-Language PathologistPrimary
Speech-Language Pathologist
Code: 235Z00000X
SL009925(PA)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (8)
Differences in the effectiveness of individual-level smoking cessation interventions by socioeconomic status.
PMID 39868569·Cochrane Database Syst Rev·2025
1-meta
Effect of Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Among Smokers Who Drink Heavily: A Randomized Clinical Trial.
PMID 35244704·JAMA Netw Open·2022
2-rct
Interventions for preventing weight gain after smoking cessation.
PMID 34611902·Cochrane Database Syst Rev·2021
1-meta
Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
PMID 25005652·JAMA·2014
4-observational
Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence.
PMID 20306175·Psychopharmacology (Berl)·2010
4-observational
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
PMID 16820547·JAMA·2006
4-observational
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
PMID 15887955·J Med Chem·2005
7-preclinical
Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization.
PMID 15528443·Science·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2553 RIDGE ROAD EXT
BADEN, PA 15005 - Phone
- (412) 716-9800
Quick Facts
- NPI
- 1912212713
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile